SenesTech, Inc. - Common Stock (SNES)
2.2200
+0.0900 (4.23%)
Senestech Inc is a biotechnology company focused on the development of innovative solutions for pest control through its proprietary platform that employs the principles of biology and technology
The company's primary aim is to create environmentally friendly products that effectively manage pest populations while minimizing harmful impacts on non-target species and ecosystems. By utilizing a unique approach to target specific species, Senestech seeks to meet the growing demand for sustainable pest management solutions in various agricultural and residential markets.
Via Benzinga · March 14, 2025
With no direct competition in the fertility control space and growing demand for non-lethal rodent management, could SNES be the next big winner? Find out in this deep-dive conversation with CEO Joel Fruendt.
Via Talk Markets · March 13, 2025
Via Benzinga · March 13, 2025

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via Benzinga · February 21, 2024
Via Benzinga · March 12, 2025

SenesTech shares lower as they exercise outstanding warrants for 374,718 shares at reduced price, plans to use proceeds for corporate purposes.
Via Benzinga · March 10, 2025

SenesTech is a small company with an innovative way for rodent control using induced infertility. They have rapidly expanded with pilot programs in major US cities and also globally in New Zealand and Australia.
Via Talk Markets · March 5, 2025
SenesTech's Evolve products are recent, but take a novel approach to rodent plagues, painlessly reducing reproduction velocity and the product is already taking off with huge distribution deals in place and rapidly improving company financials.
Via Talk Markets · February 19, 2025

SenesTech, a disruptive biotech firm, is quietly making major strides in municipal adoption, international expansion, and retail penetration.
Via Talk Markets · February 14, 2025

SenesTech is disrupting rodent control with Evolve, a fertility-based solution gaining traction in NYC & Baltimore.
Via Talk Markets · February 13, 2025

Via Benzinga · November 11, 2024

Via Benzinga · November 7, 2024

Via Benzinga · October 29, 2024

SNES stock results show that SenesTech beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024

Via Benzinga · June 20, 2024

Via Benzinga · May 22, 2024

SNES stock results show that SenesTech missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

Via Benzinga · April 25, 2024

Via Benzinga · February 22, 2024